Stem Cell Therapy International, Inc. Sample Contracts

AutoNDA by SimpleDocs
EXECUTIVE SUITE LEASE AGREEMENT WILDER CORPORATION
Lease Agreement • April 25th, 2006 • Stem Cell Therapy International, Inc. • Florida
PREFERRED STOCK PURCHASE AGREEMENT
Preferred Stock Purchase Agreement • November 3rd, 2009 • Stem Cell Therapy International, Inc. • Services-medical laboratories • New York

This Preferred Stock Purchase Agreement (“Agreement”) is entered into and effective as of November 2, 2009 (“Effective Date”), by and among Stem Cell Therapy International, Inc., a Nevada corporation (“Company”), and Socius Capital Group, LLC, a Delaware limited liability company, dba Socius Life Sciences Capital Group, LLC (including its designees, successors and assigns, “Investor”).

EMPLOYMENT AGREEMENT
Employment Agreement • November 16th, 2009 • Stem Cell Therapy International, Inc. • Services-medical laboratories • Florida

This Employment Agreement (the “Agreement”) is made and entered into as of November 10, 2009 and effective as of the first day of January 1, 2010, by and between STEM CELL THERAPY INTERNATIONAL, INC. (in the process of changing the name to Amstem Corporation), a corporation organized under the laws of Nevada (the “Company”), and David Stark, an individual (“Executive”), residing in Mill Valley, CA.

CELLS FOR LIFE (R) SCTI STEM CELL THERAPY INTERNATIONAL, INC.
Treating Physician Agreement • July 31st, 2006 • Stem Cell Therapy International, Inc. • Services-medical laboratories • Pennsylvania
STERN & CO. STEM CELL THERAPHY INTERNATIONAL CORPORATION INVESTOR & MEDIA RELATIONS CONTRACT
Investor & Media Relations Contract • April 25th, 2006 • Stem Cell Therapy International, Inc.

This letter when signed by you and returned with the first month's retainer for Stern & Co.'s investor and media relations-related services confirms that you are retaining Stern & Co. as your investor and media relations counsel for a six-month period beginning February 14, 2005 on behalf of Stem Cell Therapy International Corporation, a Nevada Corp.

SETTLEMENT AGREEMENT AND RELEASE PARTIES
Settlement Agreement • September 10th, 2009 • Stem Cell Therapy International, Inc. • Services-medical laboratories • California

This SETTLEMENT AGREEMENT AND RELEASE (the “Agreement”) is dated as of September 4, 2009 and is entered into by and among the following natural persons and corporations which are parties to various cases now pending before the Los Angeles Superior Court, as set forth below, plus one company which is not a party but highly interested in the proceedings:

AutoNDA by SimpleDocs
EMPLOYMENT AGREEMENT
Employment Agreement • September 7th, 2010 • AmStem Corp • Services-medical laboratories • Florida

THIS EMPLOYMENT AGREEMENT (the “Agreement”), dated as of September 1, 2010 (the “Effective Date”), is entered into by and between AmStem Corporation (the “Company”), and DWIGHT C. BRUNOEHLER, a resident of Maitland, Florida (the “Executive”).

January 31, 2006 Mr. John P. O'Shea President and CEO WESTMINSTER SECURITIES CORPORATION 100 Wall Street 7th Floor New York, NY 10005 REF: TERMINATION AND MODIFICATION OF ENGAGEMENT LETTER Dear Mr. O'Shea: This Termination and Modification Agreement...
Termination and Modification Agreement • April 25th, 2006 • Stem Cell Therapy International, Inc.

This Termination and Modification Agreement ("Termination Agreement") modifies, amends and terminates that certain Engagement Letter dated May 4, 2005 ("Engagement Letter") pursuant to which Stem Cell Therapy International Corp. ("SCTI") agreed to engage Westminster Securities Corporation ("Westminster") in connection with certain investment banking and financial advisory services.

AMENDED AND RESTATED REORGANIZATION AND STOCK PURCHASE AGREEMENT
Reorganization and Stock Purchase Agreement • September 25th, 2009 • Stem Cell Therapy International, Inc. • Services-medical laboratories • Nevada

This REORGANIZATION AND STOCK PURCHASE AGREEMENT dated as of September 23, 2009 (this “Agreement”) amends and restates that certain Reorganization and Stock Purchase Agreement originally entered into March 11, 2008 (as subsequently amended), (collectively, the “Original Agreement”), is by and between Stem Cell Therapy International, Inc., a Nevada corporation (“SCII”), and Histostem Co., Ltd., a Korean Company (“Histostem,” and together with SCII, the “Parties”).

RECITALS
Business Consulting and Services Agreement • April 25th, 2006 • Stem Cell Therapy International, Inc. • Florida
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!